Drug Profile
D 3967
Alternative Names: DexaminoglutethimideLatest Information Update: 25 Sep 1998
Price :
$50
*
At a glance
- Originator Celltech Group
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer